Breakthrough Flu Protection: Single Dose Could Last All Season

London, Wednesday, 24 June 2026.
RQ Bio secures $115 million to revolutionize flu prevention with a long-acting antibody, RQB01, offering full-season protection from a single dose. This could transform healthcare by reducing outbreaks and boosting productivity, especially for high-risk groups.